Acute mechanical forces cause deterioration in lung structure and function in elastase-induced emphysema

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 303, Issue 7, 2012, Pages

  Szabari, M V ^a,b   Parameswaran, H ^a   Sato, S ^a   Hantos, Z ^b   Bartolak Suki E ^a   Suki, B ^a  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

AECOPD; Exacerbation; Irreversibility; Mechanical stress

Indexed keywords

EOSIN; HEMATOXYLIN; PANCREATIC ELASTASE;

AIR CONDITIONING; AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BODY PLETHYSMOGRAPHY; CLINICAL EVALUATION; CONTROLLED STUDY; EMPHYSEMA; FUNCTIONAL RESIDUAL CAPACITY; LUNG ALVEOLUS WALL; LUNG FUNCTION; LUNG MECHANICS; LUNG STRUCTURE; MALE; MECHANICAL STRESS; MOUSE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL;

EID: 84867172333     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00217.2012     Document Type: Article

References (43)

1. Allen GB, Suratt BT, Rinaldi L, Petty JM, Bates JH. Choosing the frequency of deep inflation in mice: balancing recruitment against ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 291: L710-L717, 2006.
2. Anzueto A. Impact of exacerbations on COPD. Eur Respir Rev 19: 113-118, 2010.
3. Cantor JO, Nadkarni PP. Hyaluronan: the Jekyll and Hyde molecule. Inflamm Allergy Drug Targets 5: 257-260, 2006.
4. Donaldson GC, Seemungal T, Jeffries DJ, Wedzicha JA. Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur Respir J 13: 844-849, 1999.
5. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57: 847-852, 2002.
6. Dubois AB, Botelho SY, Bedell GN, Marshall R, Comroe JH Jr. A rapid plethysmographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects. J Clin Invest 35: 322-326, 1956.
7. Garcia-Aymerich J, Serra Pons I, Mannino DM, Maas AK, Miller DP, Davis KJ. Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax 66: 585-590, 2011.
8. Global Initiative for Chronic Obstructive Lung Disease Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf.
9. Gompertz S, Bayley DL, Hill SL, Stockley RA. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax 56: 36-41, 2001.
10. Hamakawa H, Bartolak-Suki E, Parameswaran H, Majumdar A, Lutchen KR, Suki B. Structure-function relations in an elastase-induced mouse model of emphysema. Am J Respir Cell Mol Biol 45: 517-524, 2011.
11. Hantos Z, Adamicza A, Janosi TZ, Szabari MV, Tolnai J, Suki B. Lung volumes and respiratory mechanics in elastase-induced emphysema in mice. J Appl Physiol 105: 1864-1872, 2008.
12. Hantos Z, Daroczy B, Suki B, Nagy S, Fredberg JJ. Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol 72: 168-178, 1992.
13. Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, Marconcini LA, Mecham RP, Senior RM, Shapiro SD. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 116: 753-759, 2006.
14. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363: 1128-1138, 2010.
15. Ito S, Bartolak-Suki E, Shipley JM, Parameswaran H, Majumdar A, Suki B. Early emphysema in the tight skin and pallid mice: roles of microfibril-associated glycoproteins, collagen, and mechanical forces. Am J Respir Cell Mol Biol 34: 688-694, 2006.
16. Ito S, Ingenito EP, Arold SP, Parameswaran H, Tgavalekos NT, Lutchen KR, Suki B. Tissue heterogeneity in the mouse lung: effects of elastase treatment. J Appl Physiol 97: 204-212, 2004.
17. Janosi TZ, Adamicza A, Zosky GR, Asztalos T, Sly PD, Hantos Z. Plethysmographic estimation of thoracic gas volume in apneic mice. J Appl Physiol 101: 454-459, 2006.
18. Jesudason R, Sato S, Parameswaran H, Araujo AD, Majumdar A, Allen PG, Bartolak-Suki E, Suki B. Mechanical forces regulate elastase activity and binding site availability in lung elastin. Biophys J 99: 3076-3083, 2010.
19. Kononov S, Brewer K, Sakai H, Cavalcante FS, Sabayanagam CR, Ingenito EP, Suki B. Roles of mechanical forces and collagen failure in the development of elastase-induced emphysema. Am J Respir Crit Care Med 164: 1920-1926, 2001.
20. Lakatos HF, Burgess HA, Thatcher TH, Redonnet MR, Hernady E, Williams JP, Sime PJ. Oropharyngeal aspiration of a silica suspension produces a superior model of silicosis in the mouse when compared to intratracheal instillation. Exp Lung Res 32: 181-199, 2006.
21. Lavietes MH, Smeltzer SC, Cook SD, Modak RM, Smaldone GC. Airway dynamics, oesophageal pressure and cough. Eur Respir J 11: 156-161, 1998.
22. Leith DE. Cough. Phys Ther 48: 439-447, 1968.
23. Lucey EC, Goldstein RH, Stone PJ, Snider GL. Remodeling of alveolar walls after elastase treatment of hamsters. Results of elastin and collagen mRNA in situ hybridization. Am J Respir Crit Care Med 158: 555-564, 1998.
24. Lutchen KR, Yang K, Kaczka DW, Suki B. Optimal ventilation waveforms for estimating low-frequency respiratory impedance. J Appl Physiol 75: 478-488, 1993.
25. Mercer RR, Crapo JD. Structural changes in elastic fibers after pancreatic elastase administration in hamsters. J Appl Physiol 72: 1473-1479, 1992.
26. Mishima M, Hirai T, Itoh H, Nakano Y, Sakai H, Muro S, Nishimura K, Oku Y, Chin K, Ohi M, Nakamura T, Bates JH, Alencar AM, Suki B. Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 96: 8829-8834, 1999.
27. Mouded M, Egea EE, Brown MJ, Hanlon SM, Houghton AM, Tsai LW, Ingenito EP, Shapiro SD. Epithelial cell apoptosis causes acute lung injury masquerading as emphysema. Am J Respir Cell Mol Biol 41: 407-414, 2009.
28. Namati E, Thiesse J, de Ryk J, McLennan G. Alveolar dynamics during respiration: are the pores of Kohn a pathway to recruitment? Am J Respir Cell Mol Biol 38: 572-578, 2008.
29. O'Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 155: 109-115, 1997.
30. Paggiaro PL, Dahle R. Bakran I, Frith L, Hollingworth K, Efthimiou J. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. Lancet 351: 773-780, 1998.
31. Parameswaran H, Majumdar A, Ito S, Alencar AM, Suki B. Quantitative characterization of airspace enlargement in emphysema. J Appl Physiol 100: 186-193, 2006.
32. Qiu Y, Zhu J, Bandi V, Atmar RL, Hattotuwa K, Guntupalli KK, Jeffery PK. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 168: 968-975, 2003.
33. Sapey E, Stockley RA. COPD exacerbations. 2: aetiology. Thorax 61: 250-258, 2006.
34. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161: 1608-1613, 2000.
35. Seemungal TA, Harper-Owen R, Bhowmik A, Jeffries DJ, Wedzicha JA. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J 16: 677-683, 2000.
36. Stockley RA, O'Brien C, Pye A, Hill SL. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. 2000. Chest 136: e30, 2009.
37. Suki B, Lutchen KR, Ingenito EP. On the progressive nature of emphysema: roles of proteases, inflammation, and mechanical forces. Am J Respir Crit Care Med 168: 516-521, 2003.
38. Tanabe N, Muro S, Hirai T, Oguma T, Terada K, Marumo S, Kinose D, Ogawa E, Hoshino Y, Mishima M. Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 183: 1653-1659, 2011.
39. Vlahovic G, Russell ML, Mercer RR, Crapo JD. Cellular and connective tissue changes in alveolar septal walls in emphysema. Am J Respir Crit Care Med 160: 2086-2092, 1999.
40. Wang D, Wang Y, Liu YN. Experimental pulmonary infection and colonization of Haemophilus influenzae in emphysematous hamsters. Pulm Pharmacol Ther 23: 292-299, 2010.
41. West JB. Pulmonary capillary stress failure. J Appl Physiol 89: 2483-2489, 2000.
42. Wirtz HR, Dobbs LG. Calcium mobilization and exocytosis after one mechanical stretch of lung epithelial cells. Science 250: 1266-1269, 1990.
43. Zamel N, Hogg J, Gelb A. Mechanisms of maximal expiratory flow limitation in clinically unsuspected emphysema and obstruction of the peripheral airways. Am Rev Respir Dis 113: 337-345, 1976.